Trial Outcomes & Findings for Clinical Performance of Two Daily Disposable Soft Contact Lenses (NCT NCT05138783)

NCT ID: NCT05138783

Last Updated: 2023-04-18

Results Overview

Visual Acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm of the minimum angle of resolution (logMAR). A logMAR value of 0 corresponds to 20/20 Snellen acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

129 participants

Primary outcome timeframe

Day 8 (-0/+3 days), each study lens type

Results posted on

2023-04-18

Participant Flow

Subjects were recruited from 8 investigative sites in the US.

Of the 129 enrolled, 3 subjects were screen failures prior to randomization. This reporting group includes all randomized subjects, as treated (126).

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
PRECISION1, Then Biotrue
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
Biotrue, Then PRECISION1
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
First Wear Period, 8 -0/+3 Days
STARTED
62 124
64 128
First Wear Period, 8 -0/+3 Days
COMPLETED
62 124
64 128
First Wear Period, 8 -0/+3 Days
NOT COMPLETED
0 0
0 0
Second Wear Period, 8 -0/+3 Days
STARTED
62 124
64 128
Second Wear Period, 8 -0/+3 Days
COMPLETED
62 124
64 128
Second Wear Period, 8 -0/+3 Days
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Performance of Two Daily Disposable Soft Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PRECISION1, Then Biotrue
n=62 Participants
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
Biotrue, Then PRECISION1
n=64 Participants
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
Total
n=126 Participants
Total of all reporting groups
Age, Continuous
31.4 years
STANDARD_DEVIATION 8.2 • n=5 Participants
33.5 years
STANDARD_DEVIATION 7.3 • n=7 Participants
32.4 years
STANDARD_DEVIATION 7.8 • n=5 Participants
Sex: Female, Male
Female
42 Participants
n=5 Participants
42 Participants
n=7 Participants
84 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
22 Participants
n=7 Participants
42 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants
n=5 Participants
6 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
52 Participants
n=5 Participants
58 Participants
n=7 Participants
110 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
White
57 Participants
n=5 Participants
61 Participants
n=7 Participants
118 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
Multi-racial
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Missing data
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 8 (-0/+3 days), each study lens type

Population: Full Analysis Set: All randomized subjects who were exposed to any study lenses evaluated in this clinical study with data at Day 8.

Visual Acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm of the minimum angle of resolution (logMAR). A logMAR value of 0 corresponds to 20/20 Snellen acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Outcome measures

Outcome measures
Measure
PRECISION1
n=252 eyes
Verofilcon A contact lenses worn in Period 1 or Period 2, as randomized, in both eyes during waking hours only at least 10 hours per day for -0/+3 days. A fresh pair of lenses was worn each day.
Biotrue
n=252 eyes
Nesofilcon A contact lenses worn in Period 1 or Period 2, as randomized, in both eyes during waking hours only at least 10 hours per day for -0/+3 days. A fresh pair of lenses was worn each day.
Least Squares Mean Distance Visual Acuity (VA) With Study Lenses
-0.13 logMAR
Standard Error 0.006
-0.13 logMAR
Standard Error 0.006

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PRECISION1 Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PRECISION1 NonOcular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biotrue Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biotrue NonOcular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study,
  • Publication restrictions are in place

Restriction type: OTHER